Lutetium (177Lu) oxodotreotide - Wikipedia
Lutetium (177Lu) oxodotreotide (INN) or 177Lu dotatate, brand name Lutathera, is a chelated complex of a radioisotope of the element lutetium with dotatate, used in peptide receptor radionuclide therapy. Specifically, it is used in the treatment of cancers which express somatostatin receptors. [5] .
Lutetium-177 PSMA Therapy for Prostate Cancer (Pluvicto)
Lutetium-177 (Lu-177) PSMA therapy (Pluvicto) is a new theranostic treatment that targets a specific molecule on the surface of prostate cancer cells, effectively killing the cancer cells while preserving healthy tissues.
PLUVICTO™ | Lutetium Lu 177 vipivotide tetraxetan
What is PLUVICTO ® (lutetium Lu 177 vipivotide tetraxetan)? PLUVICTO is a radiopharmaceutical used to treat adults with an advanced cancer called prostate-specific membrane antigen–positive metastatic castration-resistant …
Lutetium-177 shows significant rPFS benefit for ... - Mayo Clinic
2024年1月20日 · Mayo Clinic researchers found that lutetium-177 (177 Lu)-PSMA-617 prolonged radiographic progression-free survival (rPFS) in patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) who were taxane-naive and had progressive disease after receiving androgen receptor pathway inhibition (ARPI) therapy compared with …
177 Lu PSMA-617 Therapy, (Pluvicto) - Society of Nuclear …
177 Lutetium PSMA-617 (brand name Pluvicto) is a type of therapy known as PSMA (prostate-specific membrane antigen) targeted ligand therapy. It is prescribed for patients diagnosed with hormone-resistant metastatic prostate cancer that progressed while on chemotherapy.
Lutetium Lu 177 dotatate Uses, Side Effects & Warnings - Drugs.com
2024年4月30日 · Lutetium Lu 177 dotatate is a radioactive medicine that binds itself to a specific part of certain tumor cells, allowing the radiation to enter and destroy those cells. Lutetium Lu 177 dotatate is used to treat certain cancers of the digestive tract, …
What is Lutetium-177 - Advancing Nuclear Medicine
2023年1月18日 · Lutetium-177 (Lu-177) is a medical isotope used in targeted radionuclide therapy for treating neuroendocrine tumours and prostate cancer. It is produced in NRG’s nuclear facility and it is currently the most commonly used isotope for targeted radionuclide therapy.
Lutetium Lu 177-Dotatate - NCI - National Cancer Institute
Lutetium Lu 177-dotatate is approved to treat: Gastroenteropancreatic neuroendocrine tumors. It is used in adults and children aged 12 years and older whose cancer is somatostatin receptor positive. Lutetium Lu 177-dotatate is also being studied in the treatment of other types of cancer.
What is LUTATHERA® (lutetium Lu 177 dotatate)?
LUTATHERA ® (lutetium Lu 177 dotatate) is a prescription medicine used to treat adults and children aged 12 years and older with a type of cancer known as gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive...
Lutetium lu 177 dotatate (intravenous route) - Mayo Clinic
2024年1月31日 · Lutetium Lu 177 dotatate injection is used to treat somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including tumors of the different parts of the gut. Lutetium Lu 177 dotatate injection is a radiopharmaceutical.